Abogen Biosciences

Abogen Biosciences (Suzhou Abogen Biosciences, 苏州艾博生物科技有限公司) is an industry-leading clinical-stage biotech company founded in January 2019 and headquartered in Suzhou, China, dedicated to developing transformative medicines through messenger RNA (mRNA) innovation. The company has built full-scale in-house capabilities spanning the entire mRNA drug-development cycle — protein engineering, mRNA sequence design and synthesis, lipid nanoparticle (LNP) delivery, formulation, and commercial-scale manufacturing — underpinned by proprietary mRNA and nano-delivery technology platforms. Its pipeline covers infectious-disease prevention and tumor immunology, including an EUA-authorized product and multiple clinical-stage candidates. Abogen is a portfolio company of Qiming Venture Partners. This profile was surfaced through the API Evangelist VC-portfolio enrichment pipeline; the company publishes a corporate website but no public developer or API surface.

Abogen Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, mRNA, Pharmaceuticals, and Vaccines.

Abogen Biosciences’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologymRNAPharmaceuticalsVaccinesLife SciencesDrug DevelopmentImmunology

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.0/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/abogenbio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: abogenbio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abogenbio.png
name: Abogen Biosciences
description: Abogen Biosciences (Suzhou Abogen Biosciences, 苏州艾博生物科技有限公司) is an industry-leading clinical-stage biotech company
  founded in January 2019 and headquartered in Suzhou, China, dedicated to developing transformative medicines through messenger
  RNA (mRNA) innovation. The company has built full-scale in-house capabilities spanning the entire mRNA drug-development
  cycle — protein engineering, mRNA sequence design and synthesis, lipid nanoparticle (LNP) delivery, formulation, and commercial-scale
  manufacturing — underpinned by proprietary mRNA and nano-delivery technology platforms. Its pipeline covers infectious-disease
  prevention and tumor immunology, including an EUA-authorized product and multiple clinical-stage candidates. Abogen is a
  portfolio company of Qiming Venture Partners. This profile was surfaced through the API Evangelist VC-portfolio enrichment
  pipeline; the company publishes a corporate website but no public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/abogenbio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- mRNA
- Pharmaceuticals
- Vaccines
- Life Sciences
- Drug Development
- Immunology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://abogenbio.com
- type: Blog
  url: https://abogenbio.com/company/
- type: Support
  url: https://abogenbio.com/contact/
- type: TermsOfService
  url: https://abogenbio.com/clause/
- type: PrivacyPolicy
  url: https://abogenbio.com/privacy/
- type: DomainSecurity
  url: security/abogenbio-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence